High Intensity Focused Ultrasound Market

High Intensity Focused Ultrasound Market Size (2023 to 2028)

The global high intensity focused ultrasound market was valued at USD 327.5 million in 2023 and is anticipated to reach nearly US$ 765.5 million by 2028, with a rise in CAGR of 12.7% from 2023 to 2028.

High Intensity Focused Ultrasound Market Share Insights:

• Based on imaging technology, the ultrasound-HIFU therapy segment accounted for the major share of the global market in 2022.
• Based on indication, the oncology segment held 56.20% market share in 2022.
• Based on end-user, the hospital segment led the market in 2022.
• Based on the region, North America dominated the market in 2022.

Impact of COVID-19 on the high intensity focused ultrasound market:

The high-intensity focused ultrasound market had been negatively impacted due to the global pandemic crisis. The high strain on the healthcare system led to reduced participation in screening programs and diagnosis to surgery for cancer treatment, which decline the need for high-intensity focused ultrasound for the treatment. The initial phases of the pandemic had to postpone elective procedures, in January 2022, a study performed at the university hospital of Verona where radiotherapy was used continuously reported that there was a decline in weekly radiotherapy usage by 20.2% in April, 6.8% in May and 13.7% in June respectively, this led to decline in the number of radiotherapy procedures performed, which affecting the revenue and growth of the companies worked in the high intensity focused ultrasound market.

MARKET DRIVERS:

The growing patient population suffering from neurological disorders is one of the major factors propelling the growth of the high intensity focused ultrasound market. An estimated 11.8% population globally burdened by neurological disorders, and the prevalence of the neurological disorder is doubled after the pandemic crisis, in 1999 globally 4.0% of people affected by neurological disorders, and by 2019 the percentage of cases had doubled to 8.5%, the rising prevalence of neurological disorder need effective treatment, HIFU allows for precise targeting of specific areas within the brain and nervous system, this accuracy is vital while dealing with the delicate neurological structure, this treatment gives faster relief, and reduced the risk of infection, hence this factor majorly boosting the market growth in the upcoming years.

The rising prevalence of prostate cancer, as HIFU used to treat prostate cancer boosts the market growth further. Globally 1,660,540 people were diagnosed with prostate cancer in 2022. HIFU is a non-invasive treatment option for localized prostate cancer, this treatment option is particularly attractive to patient who are concerned about the potential side effects and complication associated with surgery, this technology enable precise targeting of cancerous tissue within the prostate, and this accuracy minimizes the risk of damage to adjacent structure and helps to preserve urinary and sexual function, as this treatment is more benefited option for the treatment of prostate cancer, hence this factor favouring the market growth during the projected period.

Technological advancements in high-intensity focused ultrasound treatment contributes to the market growth. Technology innovation brings improvement in the safety, precision, and effectiveness of HIFU treatment, advanced imaging technologies such as MRI and ultrasound have been integrated with the HIFU system to provide real-time visualization of the treatment area, this allows for targeting the more accurate treatment delivery, innovation also led to incorporate real-time monitoring which enables the healthcare provider to adjust treatment and reduced the risk of complication hence this factor also anticipated to boosting the market growth during the forecast period. The growing awareness of early diagnosis, innovation in technology, rising prevalence of cancer that need appropriate treatment, rising application of HIFU in radiotherapy, minimal procedure time, minimal side effects, faster recovery and rising cases of glaucoma fuels the market’s growth rate.

MARKET RESTRAINTS:

Limitations associated with HIFU technology, and the absence of skilled professionals are major obstacles hindering market growth. The effectiveness of HIFU technology can be restricted by the depth and size of targeted tissue, the presence of bone, gas-filled organs, and tissue barriers can hinder the propagation of ultrasound waves and limit the precise targeting of HIFU energy to the intended treatment site, HIFU treatment required skilled professional who can accurately plan and execute the procedure, the lacked skilled professional also limits the market growth. The regulatory approval for certain applications of HIFU technology might be lacking in some regions, which limits its adoption and availability, also the reimbursement policies and insurance coverage for HIFU treatment is not well-established causing a financial barrier for the patient seeking this procedure, which further hampering the growth of the market.

REPORT COVERAGE:

This research report on the global high intensity focused ultrasound market has been segmented and sub-segmented based on the imaging, indication technology, end-user and region.

High Intensity Focused Ultrasound Market - By imaging technology:

• Ultrasound- HIFU Therapy
• Magnetic Resonance Imaging- HIFU Therapy

Based on imaging technology, the ultrasound-HIFU therapy segment is expected to hold the leading share of the market during the forecast period. Real-time visualization of the target tissue and surrounding structures is provided via ultrasound imaging. This enables medical professionals to direct HIFU energy precisely to the area that needs to be treated while minimizing harm to healthy tissue. Real-time monitoring of the treatment process improves the procedure's accuracy and safety. This therapy accurately targets tumors and enhances safety and patient outcomes propelling the market growth.

The magnetic resonance imaging-HIFU therapy segment is also expected to hold a notable share during the projected period. Both patients and medical professionals find MRI-HIFU therapy to be a desirable option because of its real-time imaging, accuracy, and safety. This factor propels segmental growth.

High Intensity Focused Ultrasound Market - By Indication:

• Oncology
  • Prostate cancer
  • Rectal tumors
  • Liver tumors
  • Renal tumors
  • Breast cancer
  • Vaginal Cancer
• Skin Care
  • Anti-aging treatment
  • Skin Laxity Tightening
• Neurological Disorders
• Others
  • Uterine Fibroids
  • Benign Prostatic Hyperplasia

Based on indication, the oncology segment held 56.20% market share in 2022 and is expected to continuously dominate the market during the forecast period. Globally 20.5 million people suffer from different types of cancer, HIFU is a non-invasive treatment option for cancer, this treatment option is particularly attractive to a patient who is concerned about the potential side effects and complications associated with surgery, this technology enables precise targeting of cancerous tissue, this accuracy minimizes the risk of damage, as this treatment is a more benefited option for the treatment of cancer via radiotherapy and drive the segmental growth during the forecast period.

The neurological disorders segment is anticipated to account for a notable share of the worldwide market during the forecast period. An estimated 11.8% population globally is burdened by a neurological disorder. The rising prevalence of neurological disorder need effective treatment and HIFU allows for precise targeting of specific areas within the brain and nervous system. This accuracy is vital while dealing with the delicate neurological structure and this treatment gives faster relief and reduced the risk of infection. Hence, this segment also expected to dominate the market and favours the segmental growth during the forecast period.

High Intensity Focused Ultrasound Market – By End-user:

• Hospitals
• Ambulatory Surgical Centers
• Dermatology Clinics
• Others
• Research Institutes
• Specialty Centers

Based on end-user, the hospital segment is expected to dominate the market at the fastest CAGR during the forecast period. The rising prevalence of cancer and neurological disorder need effective treatment options, the hospital is very beneficial for proper diagnosis and medication of such disorder due to the well-established healthcare infrastructure availability in the hospital and also the availability of technological advance devices in the hospital propel the segmental growth and favouring the market growth.

The dermatology clinic segment is expected to hold considerable share of the worldwide market during the forecast period. Dermatology offices provide a variety of procedures designed to improve skin health and address cosmetic issues. Due to its non-invasive nature and capacity to produce efficient results, HIFU technology has grown in favour of dermatology clinics. The superficial to deeper tissue layers of the skin can all be targeted by HIFU. This capability of addressing several levels of skin tissue enables extensive and realistic-appearing improvements, as more benefits are associated with HIFU treatment in dermatology, propelling the segmental growth in upcoming years.

High Intensity Focused Ultrasound Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, the North American region is anticipated to hold a leading position in the global high-intensity focused ultrasound market. The rising prevalence of vaginal and vulvar cancer in this region is a major factor propelling the market growth. According to CDSCO, in November 2022, in the US, 1560 women were diagnosed with vaginal cancer, and 5230 women were diagnosed with vulvar cancer, HIFU is a non-invasive treatment option for cancer, this treatment option particularly attractive to patients who are concerned about the potential side effects and complication associated with surgery, this technology enable precise targeting of cancerous tissue, this accuracy minimizes the risk of damage, hence this region expected to favor the market growth in the upcoming years.

Europe is the second-largest regional market and is anticipated to grow at the promising CAGR during the projected period. The presence of prominent key players in the European market and increasing collaboration and partnership propelling the market growth. HIFU is a non-invasive treatment option for the various type of disorders, as the collaboration increasing between key market players in European countries led to more innovation and technological advancement in the HIFU treatment hence this region is also expected to earn more market revenue and propel the market growth during the forecast period.

The Asia-Pacific region is expected to show lucrative growth in this region and is anticipated to dominate the market at the longest CAGR during the projected period. The emerging focus of vendors on the emerging market fuel the market growth in this region, furthermore the increasing research and developmental activity and investment, also a surge in disease diagnosis and awareness propel the market growth, furthermore, this region has a remarkable opportunity for the venture capitalist and investor due to developed market are saturated in this region, hence this factor boosting the market growth in the APAC region.

Latin-America region is expected to hold a considerable market share during the forecast period. In Latin America, there is a rising demand for aesthetic operations. Treatments like HIFU that provide skin tightening, lifting, and contouring benefits are expected to be increasingly popular as people expand increasingly conscious of their appearances. Hence this region also dominates the market growth during the projected period.

The Middle East and Africa region is also expected to show lucrative growth and grow at a healthy CAGR in the global high-intensity focused ultrasound market.

KEY MARKET PLAYERS:

The prominent key player in the global High Intensity Focused ultrasound market are GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Hitachi, Ltd., Ultrasound Technologies Ltd., Johnson & Johnson Services, Inc., SonaCare Medical, LLC., EpiSonica Corporation, Profound Medical Corp., EDAP TMS, ALPINION MEDICAL SYSTEMS Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd.

RECENT MARKET DEVELOPMENTS:

• In November 2022, the firm creating the next-generation high-intensity focused ultrasound (HIFU) therapy technology, SONIRE Therapeutics Inc., was purchased by Nomura Holdings, Inc., a financial holding company with headquarters in Japan. The Nomura Holdings, Inc. investment will help SONIRE Therapeutics, Inc. create an HIFU treatment system for the treatment of pancreatic cancer and other cancers.
• In April 2021, Basal Cell Carcinoma (BCC) treatment study has been initiated by Zealand University Hospital. Following a single, 3–5-minute treatment, the trial will evaluate the safety and efficacy profile three months later. Up until the completion of the research, which is one year following therapy, secondary endpoints are monitored every third month. The investigation should be finished by December 2024.